Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Covanis, P. Jeavons (1980)
Once‐daily Sodium Valproate in the Treatment of EpilepsyDevelopmental Medicine & Child Neurology, 22
H. Wieser (1991)
Comparison of valproate concentrations in human plasma, CSF and brain tissue after administration of different formulations of valproate or valpromideEpilepsy Research, 9
D Schmidt (1977)
Fluctuation of dipropyl acetate plasma levels with one and three daily dosesPharm Weekbl (Sci), 112
T. Glauser, C. Pippenger (2000)
Controversies in Blood‐level Monitoring: Reexamining Its Role in the Treatment of EpilepsyEpilepsia, 41
J. Hughes (1981)
Advances in epileptology. XIII epilepsy international symposiumElectroencephalography and Clinical Neurophysiology, 55
Rick Davis, D. Peters, D. McTavish (1994)
Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.Drugs, 47 2
H. Stefan, W. Burr, H. Fichsel, W. Fröscher, H. Penin (1984)
Intensive Follow‐up Monitoring in Patients with Once Daily Evening Administration of Sodium ValproateEpilepsia, 25
E. Perucca (2002)
Pharmacological and Therapeutic Properties of ValproateCNS Drugs, 16
A. Beydoun, J. Sackellares, V. Shu (1997)
Safety and Efficacy of Divalproex Sodium Monotherapy in Partial EpilepsyNeurology, 48
P. Despland (1994)
A Retrospective Study of 113 Epileptic Patients Treated with Sustained‐Release ValproateEpilepsia, 35
T Mimaki, Y Fukuyama, T Abe (1990)
Clinical study of NIK-240, a new slow release granule of sodium valproate in epileptic children. Cross-over comparison to Depakine granule (in Japanese)Shonika Rinsho (Tokyo), 43
M. Bialer (1992)
Pharmacokinetic Evaluation of Sustained Release Formulations of Antiepileptic DrugsClinical Pharmacokinetics, 22
M. Thibault, W. Blume, J. Saint‐Hilaire, R. Zakhari, K. Sommerville (2002)
Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizuresEpilepsy Research, 50
J. Hughes (1990)
Advances in epileptologyElectroencephalography and Clinical Neurophysiology, 76
I. Ieiri, T. Morioka, T. Ichimiya, S. Nishio, M. Fukui, K. Ohtsubo, S. Higuchi (1995)
Pharmacokinetic Study of Valproic Acid Sustained‐Release Preparation in Patients Undergoing Brain SurgeryTherapeutic Drug Monitoring, 17
T. Imaizumi, T. Izumi, Y. Fukuyama (1992)
A comparative clinical and pharmacokinetic study of a new slow-release versus conventional preparations of valproic acid in children with intractable epilepsyBrain and Development, 14
D. Turnbull, M. Rawlins, D. Weightman, D. Chadwick (1983)
Plasma concentrations of sodium valproate: Their clinical valueAnnals of Neurology, 14
J Barre, Y Berger (1989)
Fourth international symposium on sodium valproate and epilepsy
Martina Rinnerthaler, G. Luef, Joerg Mueller, K. Seppi, J. Wissel, E. Trinka, G. Bauer, W. Poewe (2005)
Computerized Tremor Analysis of Valproate‐induced Tremor: A Comparative Study of Controlled‐release versus Conventional ValproateEpilepsia, 46
J. Doughty, G. Baker, A. Jacoby, V. Lavaud (2003)
Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsyEpilepsy & Behavior, 4
T. Goggin, C. Casey, N. Callaghan (1986)
Serum levels of sodium valproate, phenytoin and carbamazepine and seizure control in epilepsy.Irish medical journal, 79 6
D. Roberts, D. Easter, G. O'bryan-tear (1996)
Epilim chrono: a multidose, crossover comparison of two formulations of valproate in healthy volunteers.Biopharmaceutics & drug disposition, 17 2
L. Gram, H. Flachs, Annelise Wurtz‐Jørgensen, J. Parnas, B. Andersen (1979)
Sodium Valproate, Serum Level and Clinical Effect in Epilepsy: A Controlled StudyEpilepsia, 20
M Bialer (1992)
Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implicationsClin Pharmacokinet, 22
E Perucca (2002)
Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experienceCNS Drugs, 16
D. Chadwick (1985)
Concentration-Effect Relationships of Valproic AcidClinical Pharmacokinetics, 10
Iben Gjerløff, J. Arentsen, J. Alving, B. Secher (1984)
Monodose versus 3 daily doses of sodium valproate: a controlled trialActa Neurologica Scandinavica, 69
O. Brouwer, M. Pieters, P. Edelbroek, A. Bakker, Amanda Geel, T. Stijnen, A. Jennekens-Schinkel, J. Lanser, A. Peters (1992)
Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performancesEpilepsy Research, 13
T Mimaki, Y Fukuyama, S Otsuka (1991)
Clinical pharmacokinetics of NIK-240, a new slow release granule of sodium valproate, in epileptic children (in Japanese)Shonika Rinsho (Tokyo), 44
A Beydoun, JC Sackellares, V Shu (1997)
Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trialNeurology, 48
Although our results should be confirmed by a larger study, they suggest that the efficacy and tolerability of chrono valproate is similar to that of conventional valproate, and that the main advantage is the once-daily administration.
European Journal of Clinical Pharmacology – Springer Journals
Published: Aug 2, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.